Skip to main content

Kidney cancer educational conference at VICC set Sept. 10

Sep. 2, 2016, 9:57 AM

Kidney cancer patients, family members, health care providers and members of the public are invited to attend a free educational workshop about the disease to be held at Vanderbilt-Ingram Cancer Center (VICC).

The Kidney Cancer Association Patient and Survivor Conference will be held Saturday, Sept. 10, 8 a.m. to 2 p.m., in the Preston Research Building, 2220 Pierce Ave., Suite 898. Registration begins at 8 a.m. and a light breakfast will be served.

Approximately 62,700 patients will be diagnosed with kidney cancer in 2016 and 14,240 are expected to die from the illness, according to the National Cancer Institute, a division of the National Institutes of Health.

The VICC seminar is designed to provide the latest information about the diagnosis and treatment of various types of kidney cancer.

The keynote speaker for the conference is Eric Jonasch, M.D., professor in the Department of Genitourinary Medical Oncology at MD Anderson Cancer Center, Houston, Texas.

Other speakers and topics:

  • Kimryn Rathmell, M.D., Ph.D., Cornelius A. Craig Professor of Medicine and director of the Division of Hematology/Oncology at VICC, will provide an overview of advances for kidney cancer in the last 20 years;
  • Kelvin Moses, M.D., Ph.D., assistant professor of Urologic Surgery, will detail modern considerations in surgery;
  • Geoffrey Wile, M.D., associate professor of Clinical Radiology and Radiological Sciences, will explain the use of imaging in kidney cancer;
  • M. Rachel McDowell, MSN, ACNP-BC, will discuss pain and symptom management;
  • Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, will focus on the use of stereotactic body radiation therapy (SBRT);
  • Scott Haake, M.D., instructor in Medicine, will provide an update on the genomic landscape of renal cell carcinomas;
  • David Chism, M.D., M.S., assistant professor of Medicine, will provide an overview of adjuvant therapies for renal cell carcinoma; and
  • Michael Lawing, director of the Kidney Cancer Association, will speak to participants about the organization’s support for research as well as patient and family assistance programs.

Refreshments and a box lunch will be provided to all participants. To reserve a seat, register online at

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice